A Landscape of Artificial Intelligence (AI) In Pharmaceutical R&D

Where you find opportunities to grow

* Can't find your brand, product, service? Join BPT Marketplace

Healthcare Technologies


TrialScope Expands Leadership Team with New Chief Commercial Officer

   by Darcy Grabenstein    209
TrialScope Expands Leadership Team with New Chief Commercial Officer

Chris Venezia to Leverage His Expertise in Healthcare Technology

TrialScope, the global leader in clinical trial transparency, has hired Chris Venezia as Chief Commercial Officer, expanding its executive team.

Much of Venezia’s career has been focused on pharmaceutical and healthcare technologies. A frequent speaker and trainer, he served as Chief Revenue Officer of Signals Analytics. Prior to that, he worked in global sales at both Clarivate Analytics and Thomson Reuters, and served as vice president of sales at GlobalData Plc.

OKRA smashes target of 2 million validated predictions for big Pharma, 6 months early

   by Marina Gonzalo    385
OKRA smashes target of 2 million validated predictions for big Pharma, 6 months early

Cambridge, UK, 19 June 2020 - OKRA, a leading provider of Artificial Intelligence (AI) driven analytics for Life Sciences, today hit an important milestone, delivering 2 million validated predictions so far in 2020, smashing through its yearly target in just half the expected time. This underscores OKRA’s achievements in empowering the pharmaceutical industry with explainable, real-time AI solutions.

[Interview] Shaping European Life Sciences with AI

   by Andrii Buvailo    826
[Interview] Shaping European Life Sciences with AI

There is a great deal of hype and a lot of misconceptions among life science experts as to how AI can or can’t be applied in pharmaceutical research and business. Judging by the rapidly increasing number of AI-involved deals and partnerships tapped by big pharma recently, it becomes obvious that life sciences decision-makers are eager to understand what this new and disruptive technology can bring to the table, and how it can be adopted efficiently with tangible ROI.

In order to get valuable first-hand insight and new ideas about the technology and its emerging role in the life sciences industry, I have asked several questions to Dr. Loubna Bouarfa, Founder and CEO at ​OKRA Technologies ― a leading AI company for healthcare, which builds a sophisticated AI-driven engine specialized in supporting faster and more accurate decisions for life science executives and field teams. Loubna is also a member of the European Union AI High-Level Expert Group (HLEG) and the winner of several prestigious awards, such as MIT Innovator Under 35 and Forbes Top 50 European Women in Technology. Last year, OKRA was named the Best Female-Led Startup at the StartUp Europe Awards.

COVID-19 Forcing You To Go Digital? You’re Missing A Trick

   by Rasim Shah    636
COVID-19 Forcing You To Go Digital? You’re Missing A Trick

Moments of crisis always mean change.

In these times, it’s tempting to reach for quotes from leaders who successfully navigated through turbulent times. "Never let a good crisis go to waste," is one often attributed to Churchill and requires us to remain level-headed despite the widespread panic. Companies founded during times of turmoil, like GE, IBM, and Microsoft, know that if they can make their business work during times of upheaval, they can go on to be even more successful in times of stability.